New Market Research Report: Pacific Edge Limited (PEB) - Product Pipeline Analysis, 2013 Update
Pacific Edge Limited (PEB) is a cancer diagnostics service provider. The company discovers and commercializes diagnostic and prognostic technology for the early detection and monitoring of cancer. It identifies gene and protein signatures for the development of better cancer management tools by combining molecular biology and gene expression analysis and signature development. The company's products include Cxbladder and Cxcolorectal. PEB's Cxcolorectal is a prognostic gene signature for patients diagnosed with stage II or stage III colorectal cancer. Its Cxbladder is...
View full press release